1. Home
  2. PASG vs RDI Comparison

PASG vs RDI Comparison

Compare PASG & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASG

Passage Bio Inc.

HOLD

Current Price

$7.83

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

RDI

Reading International Inc

HOLD

Current Price

$1.08

Market Cap

23.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PASG
RDI
Founded
2017
1937
Country
United States
United States
Employees
27
2025
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
23.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PASG
RDI
Price
$7.83
$1.08
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$23.50
N/A
AVG Volume (30 Days)
30.3K
20.6K
Earning Date
05-26-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.94
52 Week High
$20.00
$1.65

Technical Indicators

Market Signals
Indicator
PASG
RDI
Relative Strength Index (RSI) 37.40 53.42
Support Level $6.71 $1.07
Resistance Level $7.72 $1.16
Average True Range (ATR) 0.77 0.06
MACD 0.02 0.01
Stochastic Oscillator 16.73 79.49

Price Performance

Historical Comparison
PASG
RDI

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

Share on Social Networks: